At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacogenetics and Cardiovascular Events
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted Oct 15, 2004·Updated Aug 21, 2008
In Brief
An observational study for Cardiovascular Diseases and 4 related conditions. Completed.
Detailed Summary
To assess interactions between selected cardiovascular medications and genes in the incidence of heart attack, stroke, and atrial fibrillation, an irregular heartbeat.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Atrial Fibrillation, Cerebrovascular Accident, Heart Diseases, Myocardial Infarction
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2003
First PostedOct 2004
Primary CompletionAug 2008
TodayJul 2026
First PostedOct 15, 2004
Enrollment StartSep 1, 2003
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 21.7 years ago